Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
1,110.341,110.371,117.241,097.84
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
620.54620.54622.67611.42
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
1,159.201,160.591,177.621,156.21
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
1,753.441,749.081,762.011,724.74
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
648.80649.58655.73643.68
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
832.49832.07833.09826.15
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
219.16219.16219.19214.82
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
3,113.363,120.793,143.643,105.16
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
926.67927.99930.54910.08
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
1,489.611,499.051,499.051,474.35
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
2,423.262,438.162,443.462,399.83
600196:SHA
Shanghai Fosun Pharmaceutical (Group) Ord Shs A
CN¥25.59
-0.16%
(-0.040) 1D
Apr 22, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600196...
Open
CN¥25.65
High
CN¥25.82
Low
CN¥25.48
Mkt. cap
64.18B
Avg. vol.
17.70M
Volume
17.64M
P/E ratio
20.09
52-wk high
CN¥33.10
52-wk low
CN¥23.30
EPS
CN¥1.27
Shares outstanding
2.01B
No. of employees
41K
News stories
From sources across the web
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs A
CEOLiu Yi | Wen Deyong
Employees40.6K
Founded1994
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
9.42B
10.09B
9.88B
12.27B
Cost of goods sold
4.92B
5.22B
5.08B
5.65B
Cost of revenue
4.92B
5.22B
5.08B
5.65B
Research and development expenses
737.45M
979.21M
1.01B
1.28B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.10B
3.14B
3.10B
4.44B
Operating expense
3.85B
4.19B
4.04B
5.92B
Total operating expenses
8.77B
9.41B
9.12B
11.57B
Operating income
647.22M
685.50M
758.38M
699.05M
Other non operating income
-24.08M
-4.87M
-116.85M
107.33M
EBT including unusual items
1.35B
1.37B
1.12B
1.27B
EBT excluding unusual items
1.65B
1.16B
1.49B
1.10B
Income tax expense
405.98M
212.30M
162.98M
82.80M
Effective tax rate
30.13%
15.49%
14.57%
6.50%
Other operating expenses
6.04M
49.69M
-92.19M
117.57M
Net income
764.76M
937.21M
821.33M
847.27M
Net profit margin
8.12%
9.28%
8.31%
6.91%
Earnings per share
-
-
-
-
Interest and investment income
1.36B
925.83M
1.05B
732.13M
Interest expense
-329.53M
-323.25M
-321.25M
-291.32M
Net interest expenses
1.03B
602.58M
727.28M
440.80M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.28B
1.38B
1.39B
1.47B
Gain or loss from assets sale
-
-2.12M
2.12M
-69.35M
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more